Cargando…

Development of Multidisciplinary Anticoagulation Management Guidelines for Patients Receiving Durable Mechanical Circulatory Support

Patients receiving durable mechanical circulatory support (MCS) require life-long anticoagulation with a vitamin K antagonist (VKA). Due to alternations in hemostasis, concomitant therapy with antiplatelet agents and critical illness, they are at increased risk of thromboembolic and bleeding complic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levesque, Amy A., Lewin, Andrea R., Rimsans, Jessica, Sylvester, Katelyn W., Coakley, Lara, Melanson, Frank, Mallidi, Hari, Mehra, Mandeep, Givertz, Michael M., Connors, Jean M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714942/ https://www.ncbi.nlm.nih.gov/pubmed/30907120 http://dx.doi.org/10.1177/1076029619837362

Ejemplares similares

Durable Mechanical Circulatory Support versus Organ Transplantation: Past, Present, and Future
por: Anand, Jatin, et al.
Publicado: (2015)

94. Infectious Complications of Left Ventricular Assist Devices
por: Harris, Courtney, et al.
Publicado: (2021)

Overcoming barriers to integrating direct oral anticoagulants into existing anticoagulation management services
por: Sylvester, Katelyn W., et al.
Publicado: (2018)

Durable mechanical circulatory support across the Asia-Pacific region
por: Sivathasan, Cumaraswamy, et al.
Publicado: (2020)

Optimization of DOAC management services in a centralized anticoagulation clinic
por: Sylvester, Katelyn W., et al.
Publicado: (2022)

Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA
por: Kelly, Julie, et al.
Publicado: (2021)

The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients
por: Woolley, Ann E., et al.
Publicado: (2022)

Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin
por: Ting, Clara, et al.
Publicado: (2018)

87. Heart and Lung Transplants From HCV-Viremic Donors to Uninfected Patients: Longer-Term Follow-Up
por: Woolley, Ann E, et al.
Publicado: (2019)

Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy
por: McLaughlin, Kevin, et al.
Publicado: (2019)

Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
por: Sylvester, Katelyn W, et al.
Publicado: (2013)

Antibody Responses to COVID-19 Vaccination in Left Ventricular Assist Devices
por: Jering, K., et al.
Publicado: (2022)

Perioperative management of patients with undergoing durable mechanical circulatory support
por: Hulde, Nikolai, et al.
Publicado: (2020)

Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
por: Shah, Sachin P., et al.
Publicado: (2016)

Commentary: Mending a broken heart: The use of durable mechanical circulatory support
por: Pagani, Francis D.
Publicado: (2021)

Management of an acute catecholamine-induced cardiomyopathy and circulatory collapse: a multidisciplinary approach
por: Casey, R T, et al.
Publicado: (2017)

Durable Mechanical Circulatory Support in Adult Congenital Heart Disease: Reviewing Clinical Considerations and Experience
por: Saef, Joshua, et al.
Publicado: (2022)

Impact of a Multidisciplinary Team Approach on Extracorporeal Circulatory Life Support-Bridged Heart Transplantation
por: Lee, Jae Jun, et al.
Publicado: (2021)

Heparin-induced thrombocytopaenia complicating cardiogenic shock requiring durable mechanical circulatory support: a case report
por: Cangialosi, Peter, et al.
Publicado: (2023)

Comparison of 4F‐PCC in obese and nonobese patients with life‐threatening bleeding or requiring emergent surgery
por: Rimsans, Jessica, et al.
Publicado: (2021)

Short-term Outcomes in Ambulatory Heart Failure during the COVID-19 Pandemic: Insights from Pulmonary Artery Pressure Monitoring
por: Almufleh, Aws, et al.
Publicado: (2020)

Physical rehabilitation in the awake patient receiving extracorporeal circulatory or gas exchange support
por: Salna, Michael, et al.
Publicado: (2020)

Evaluation of Thrombocytopenia in Patients Receiving Percutaneous Mechanical Circulatory Support With an Impella Device
por: Houry, Erin A., et al.
Publicado: (2022)

Prognosis in Patients With Cardiogenic Shock Who Received Temporary Mechanical Circulatory Support
por: Kondo, Toru, et al.
Publicado: (2022)

Anticoagulant-related bleeding in patients receiving anticoagulant therapy over 10 years
por: Zhu, Lihong, et al.
Publicado: (2023)

When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021)

Acute Stroke Treatment in Patients Receiving Direct Oral Anticoagulants: Is it Time to Review the Guidelines?
por: Ojha, Pawan K., et al.
Publicado: (2023)

Premortem anticoagulation timing and dose in donation after circulatory death: multicentre study of associations with graft function
por: Kramer, Andreas H., et al.
Publicado: (2022)

Perioperative Considerations and Management of Patients Receiving Anticoagulants
por: Shaikh, Safiya Imtiaz, et al.
Publicado: (2017)

Safety of ECT in patients receiving an oral anticoagulant
por: Centanni, Nicolette R., et al.
Publicado: (2021)

Management of therapeutic unfractionated heparin in COVID‐19 patients: A retrospective cohort study
por: Weeks, Lachelle D., et al.
Publicado: (2021)

Impact of Fried Frailty Phenotype on Postoperative Outcomes After Durable Contemporary Mechanical Circulatory Support: A Single-Center Experience
por: Ajibawo, Temitope, et al.
Publicado: (2022)

Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant
por: Cannon, Christopher P., et al.
Publicado: (2023)

Anticoagulation in COVID-19: reaction to the ACTION trial
por: Berger, Jeffrey S, et al.
Publicado: (2021)

Creating an Interprofessional guideline to support patients receiving oral anticoagulation therapy: a Delphi exercise
por: Damen, Nikki L., et al.
Publicado: (2019)

COVID-19 and its implications for thrombosis and anticoagulation
por: Connors, Jean M., et al.
Publicado: (2020)

Dental management of patients receiving anticoagulant and/or antiplatelet treatment
por: Mingarro-de-León, Ana, et al.
Publicado: (2014)

Evaluation of bleeding in patients receiving direct oral anticoagulants
por: Hellenbart, Erika L, et al.
Publicado: (2017)

Mortality in cardiogenic shock patients receiving mechanical circulatory support: a network meta-analysis
por: Zhang, Qun, et al.
Publicado: (2022)

Reducing Error in Anticoagulant Dosing via Multidisciplinary Team Rounding at Point of Care
por: Sharma, Munish, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3gs1qjo0k0fkvomebbad8kjn4a